Ferulic acid in combination with PARP inhibitor sensitizes breast cancer cells as chemotherapeutic strategy
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference18 articles.
1. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial;Audeh;Lancet,2010
2. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin;Bhattacharyya;J. Biol. Chem.,2000
3. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005
4. MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability;Choi;eLife,2014
5. Eitsuka, T., Tatewaki, N., Nishida, H., Kurata, T., Nakagawa, K., and Miyazawa, T. Synergistic inhibition of cancer cell proliferation with a combination of delta-tocotrienol and ferulic acid. Biochem. Biophys. Res. Commun. 453, 606–611.
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In vitro and in silico analyses of cytoprotective, antigenotoxic and antimutagenic potential of Phlomis pungens var. hirta extracts against oxidative damage;2024-08-20
2. Finger millet (Eleusine coracana L.): from staple to superfood—a comprehensive review on nutritional, bioactive, industrial, and climate resilience potential;Planta;2024-08-17
3. Molecular Evidence of the Bio-activities of Traditional Home Medicine Ingredients;Current Topics in Medicinal Chemistry;2024-07-02
4. Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity;Microbiome;2024-05-14
5. Phenolic metabolites as therapeutic in inflammation and neoplasms: Molecular pathways explaining their efficacy;Pharmacological Research;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3